These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 520175

  • 1. [Improvement of growth-hormone stimulation with l-dopa/l-carbidopa by simultaneous administration of propranolol (author's transl)].
    Schönberger W, Grimm W, Ziegler R.
    Dtsch Med Wochenschr; 1979 Dec 21; 104(51):1811-3. PubMed ID: 520175
    [Abstract] [Full Text] [Related]

  • 2. The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.
    Schönberger W, Grimm W, Ziegler R.
    Eur J Pediatr; 1977 Dec 30; 127(1):15-9. PubMed ID: 606555
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature.
    Philippi H, Pohlenz J, Grimm W, Koffler T, Schönberger W.
    Acta Paediatr; 2000 Apr 30; 89(4):442-6. PubMed ID: 10830457
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan 30; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep 30; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F.
    MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540
    [Abstract] [Full Text] [Related]

  • 17. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct 14; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.
    Blair ML, Reid IA, Keil LC, Ganong WF.
    J Pharmacol Exp Ther; 1979 Sep 14; 210(3):368-72. PubMed ID: 480187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.